Clincosm LogoSign in Get a demo

Lymphoma, Non-Hodgkin

Showing NaN - NaN of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States

Completed
Has Results
  • Non-Hodgkin's Lymphoma, Relapsed
  • +8 more
  • PBCAR20A
  • +2 more
  • Duarte, California
  • +4 more
Jan 4, 2023

Lymphoma, Follicular, Lymphoma, Mantle-Cell, Marginal Zone Lymphoma Trial in United States (ADI-001, Fludarabine,

Recruiting
  • Lymphoma, Follicular
  • +5 more
  • ADI-001
  • +2 more
  • Stanford, California
  • +6 more
Oct 19, 2022

Non-Hodgkin's Lymphoma and Hodgkin's Disease

Recruiting
  • Lymphoma, Non-Hodgkin
  • Hodgkin's Disease
    • Stanford, California
      Stanford University School of Medicine
    Sep 9, 2022

    Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid

    Active, not recruiting
    • Mycoses
    • +5 more
    • anti-thymocyte globulin
    • +2 more
    • Stanford, California
      Stanford University School of Medicine
    Jun 16, 2022

    Allogeneic Gamma Delta (?d) CAR T Cells

    Enrolling by invitation
    • Lymphoma, Follicular
    • +5 more
    • ADI-001
    • Stanford, California
    • +4 more
    Jun 7, 2022

    Lymphoma, Non-Hodgkin, Lymphoma, Nonhodgkin, Lymphoma, B-Cell Trial in United States (lisocabtagene maraleucel)

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • +3 more
    • lisocabtagene maraleucel
    • Gilbert, Arizona
    • +40 more
    Apr 22, 2022

    Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

    Enrolling by invitation
    • Lymphoma, B-Cell
    • +4 more
    • Burbank, California
    • +90 more
    Mar 31, 2022

    Lymphoma, Non-Hodgkin Trial in United States (Hematopoietic Stem Cell Transplant)

    Completed
    Has Results
    • Lymphoma, Non-Hodgkin
    • Hematopoietic Stem Cell Transplant
    • Duarte, California
    • +20 more
    Dec 7, 2021

    Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases Trial in Stanford (Sirolimus, MMF, BCNU)

    Completed
    • Leukemia
    • +3 more
    • Stanford, California
      Stanford University School of Medicine
    Sep 16, 2021

    Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

    No longer available
    • Disease, Hodgkin
    • +3 more
    • brentuximab vedotin
    • Stanford, California
    • +30 more
    Sep 17, 2020

    Bone Marrow Transplant Failure, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral Trial in Canada, United States (Nilotinib)

    Completed
    • Bone Marrow Transplant Failure
    • +2 more
    • Stanford, California
    • +4 more
    Apr 13, 2020

    Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)

    Completed
    Has Results
    • Lymphoma, Non-Hodgkin
    • +6 more
    • Duarte, California
    • +41 more
    Mar 4, 2020

    Lymphoma, B-cell, Lymphoma, Non-Hodgkin, Diffuse Large B-cell Lymphoma (DLBCL) Trial in Stanford (Autologous hematopoietic stem

    Terminated
    Has Results
    • Lymphoma, B-cell
    • +3 more
    • Autologous hematopoietic stem cell transplantation (auto-HSCT)
    • +14 more
    • Stanford, California
      Stanford University School of Medicine
    May 11, 2018

    Lymphoma, Non-Hodgkin Trial in Stanford (Cyclophosphamide, BCNU, Etoposide)

    Terminated
    Has Results
    • Lymphoma, Non-Hodgkin
    • Stanford, California
      Stanford University School of Medicine
    Jan 17, 2018

    Leukemia, Lymphoma, Non-Hodgkin Trial in Stanford (Atorvastatin)

    Completed
    Has Results
    • Leukemia
    • Lymphoma, Non-Hodgkin
    • Stanford, California
      Stanford University School of Medicine
    Oct 25, 2017

    Lymphoma, Non-Hodgkin Trial in Stanford (Bexxar (tositumomab), External beam radiotherapy (XRT), Potassium Iodide (KI))

    Terminated
    Has Results
    • Lymphoma, Non-Hodgkin
    • Bexxar (tositumomab)
    • +2 more
    • Stanford, California
      Stanford University School of Medicine
    Feb 9, 2017

    Lymphoma, Non-Hodgkin, Lymphoma, Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell Trial in Stanford (PF-3512676, Local

    Completed
    Has Results
    • Lymphoma, Non-Hodgkin
    • +3 more
    • Stanford, California
      Stanford University School of Medicine
    Jan 24, 2017

    Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in France, United States (brentuximab vedotin)

    Completed
    Has Results
    • Disease, Hodgkin
    • +2 more
    • brentuximab vedotin
    • Birmingham, Alabama
    • +16 more
    Dec 7, 2016

    Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Canada, United States (brentuximab vedotin,

    Completed
    Has Results
    • Lymphoma, B-Cell
    • +3 more
    • Birmingham, Alabama
    • +33 more
    Oct 14, 2016

    B-Receptor Signaling in Cardiomyopathy

    Completed
    • Carcinomas
    • +37 more
      • Stanford, California
        Stanford University School of Medicine
      Nov 16, 2015

      Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Worldwide (SGN-40, , rituximab)

      Terminated
      • Lymphoma, Large B-Cell, Diffuse
      • Lymphoma, Non-Hodgkin
      • Birmingham, Alabama
      • +65 more
      Feb 6, 2015

      Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Germany, United States (brentuximab vedotin)

      Completed
      • Disease, Hodgkin
      • +2 more
      • brentuximab vedotin
      • Birmingham, Alabama
      • +8 more
      Dec 11, 2014

      Lymphoma, Non-Hodgkin, Blood and Marrow Transplant (BMT) Trial in Stanford (90Y Ibritumomab tiuxetan)

      Completed
      • Lymphoma, Non-Hodgkin
      • Blood and Marrow Transplant (BMT)
      • 90Y Ibritumomab tiuxetan
      • Stanford, California
        Stanford University School of Medicine
      Jun 5, 2012

      Lymphoma, Non-Hodgkin, Lymphomas: Non-Hodgkin, Lymphomas: Non-Hodgkin Cutaneous Lymphoma Trial in Stanford (Rituximab,

      Completed
      • Lymphoma, Non-Hodgkin
      • +8 more
      • Stanford, California
        Stanford University School of Medicine
      May 31, 2011

      Lymphoma, Non-Hodgkin, Leukemia, Blood and Marrow Transplant (BMT) Trial in Stanford (ablative allogeneic hematopoietic cell

      Completed
      • Lymphoma, Non-Hodgkin
      • +3 more
      • ablative allogeneic hematopoietic cell transplantation
      • Stanford, California
        Stanford University School of Medicine
      Oct 7, 2010